Advertisement
Screener

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) ROI

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) ROI

  • 2026-06-30: ROI -44.68%.
  • 2026-03-31: ROI -14.32%.
  • 2025-12-31: ROI -17.00%.
  • 2025-09-30: ROI -23.67%.

Complete source-backed roi history.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30-44.68%
2026-03-31-14.32%
2025-12-31-17.00%
2025-09-30-23.67%
2025-06-30-38.70%
2025-03-31-43.78%
2024-12-31-47.47%
2023-09-30-39.85%

Annual ROI

DateROI
2025-12-31-17.00%
2024-12-31-47.47%

Similar stocks

Stock NameCountryMarket CapPE Ratio
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Greenland Mines Ltd (GRML)United States$2.362B